Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00223210 · ClinicalTrials.gov registry record · Phase 4
An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT00223210 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT00223210, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if quetiapine add-on therapy is associated with a decrease in cocaine use and craving and a greater improvement in mood.
Interventions
- DRUG Quetiapine
- DRUG PLacebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2005-11 |
| Est. Completion | 2007-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00223210
The ClinicalTrials.gov registry entry for NCT00223210 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Quetiapine is the first listed.
NCT00223210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00223210 about?
NCT00223210 is a clinical study titled "An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence". The purpose of this study is to determine if quetiapine add-on therapy is associated with a decrease in cocaine use and craving and a greater improvement in mood.
What is the current status of trial NCT00223210?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2005-11. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00223210?
The interventions under investigation include: Quetiapine (DRUG), PLacebo (DRUG).
Who is sponsoring clinical trial NCT00223210?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.